ZBH — ZIMMER BIOMET HOLDINGS, INC.

—
NYSE · Health Care · Health Care Equipment & Supplies · CIK 1136869 ·
Last close
$102.09
Market Cap
$19.32B
52W High
$112.55
52W Low
$78.70
ADV30
2,352,027
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 2,062,900,000 1,468,400,000 341,500,000 191,600,000 23,538,600,000 399,900,000 10,813,000,000
Jun 2026 2,177,000,000 1,541,500,000 374,000,000 198,300,000 22,797,800,000 410,000,000 10,165,300,000
Mar 2026 2,086,700,000 1,510,500,000 395,100,000 238,100,000 22,721,600,000 424,200,000 10,040,000,000
Dec 2025 2,243,700,000 1,451,300,000 282,600,000 139,300,000 23,091,700,000 591,900,000 10,385,900,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,884,600,000
Investing CF
$-1,215,100,000
Financing CF
$-1,564,500,000
CapEx
$-377,300,000
Dividends Paid
$-186,700,000
Buybacks
$-829,300,000
EPS Diluted TTM
$4.41
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$12,101,000,000
Inventory
$2,367,200,000
Receivables
$1,816,000,000
ST Investments
—
EBIT TTM
$1,173,000,000
Pretax Income TTM
$884,500,000
Interest Exp TTM
$288,500,000
Analysts
21

Yahoo Snapshot (yfinance, live)

Total Revenue
$8,570,399,744
EBITDA
$2,541,299,968
Free Cash Flow
$1,442,050,048
Enterprise Value
$27,223,717,888
Total Cash
$426,900,000
Total Debt
$7,657,299,968
Shares Out
189,253,888
Trailing EPS
$3.96
Book Value
$66.89
ROE
6.0%
ROA
3.8%
Div Yield
0.91%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 8,231,500,000 1,356,200,000 705,100,000 23,091,700,000 10,385,900,000 12,697,700,000 1,697,100,000
Dec 2024 7,678,600,000 1,528,300,000 903,800,000 21,365,300,000 8,889,100,000 12,468,100,000 1,499,400,000
Dec 2023 7,394,200,000 1,451,300,000 1,024,000,000 21,496,900,000 9,008,800,000 12,480,500,000 1,581,600,000
Dec 2022 6,939,900,000 1,192,100,000 231,400,000 21,066,000,000 9,039,000,000 12,020,300,000 1,284,700,000

TTM Snapshot

Revenues TTM
$8,508,800,000
NetIncome TTM
$806,700,000
OpCashFlow TTM
—
Assets (Latest)
$22,797,800,000
Forward EPS
$8.98

Max Pain — expiry 2027-01-15

max pain strike: $100.00 · spot: $103.32 · call oi: 1,499 · put oi: 2,049
Expected Move to 2027-01-15: ±$12.17 (11.78%) — implied range $91.15 – $115.49 · ATM straddle on $105.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
STE STERIS plc $25.00B $257.41 —
SOLV Solventum Corp $14.63B $86.06 —
GKOS GLAUKOS Corp $14.40B $243.25 —
FSNUF Fresenius SE & Co. KGaA $26.39B $46.86 —
BAX BAXTER INTERNATIONAL INC $13.33B $25.76 —

News headlines (Yahoo Finance, 1h cache)

Is Wall Street Bullish or Bearish on Zimmer Biomet Stock?
2026-11-17 13:04 · Yahoo
Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London
2026-11-09 12:30 · Yahoo
Zimmer Biomet’s Q3 2026 earnings call: our top 5 analyst questions
2026-11-08 23:01 · Yahoo
What Zimmer Biomet (ZBH) Said on Its Q3 Earnings Call
2026-11-08 22:14 · Yahoo
Zimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery
2026-11-06 12:30 · Yahoo
Zimmer Biomet Sees Stronger Growth Ahead in 2027 Despite Knee Weakness, RBC Says
2026-11-05 17:48 · Yahoo
Zimmer Biomet Stock Rises On Raised 2026 Guidance And Robotics Push
2026-11-05 09:18 · Yahoo
Zimmer Biomet Holdings Inc (ZBH) (Q3 2026) Earnings Call Highlights: Guidance Raised as Hips, S. ...
2026-11-05 07:07 · Yahoo
Zimmer Biomet (ZBH) Q3 2026 Earnings Call Transcript
2026-11-04 18:48 · Yahoo
Zimmer raises sales forecast despite slower knee business
2026-11-04 17:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.